Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Colchicine + NSAID is a combination therapy involving the use of colchicine, a microtubule polymerization inhibitor with anti-inflammatory properties, and a non-steroidal anti-inflammatory drug (NSAID), which inhibits cyclooxygenase enzymes to reduce prostaglandin synthesis and inflammation. This combination is primarily used for the treatment of acute gout flares and recurrent pericarditis. Colchicine disrupts neutrophil function and migration, thereby reducing inflammation in conditions like gout, while NSAIDs provide additional pain relief and anti-inflammatory effects by blocking prostaglandin production. The combination may be considered when monotherapy is insufficient or in cases of severe or polyarticular flares[3][4][10]. Both drugs are small molecules taken orally.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on colchicine + nsaid.